Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Decreased Myelin Content and Associated Cognitive Performance in Adults Living with Perinatally-Acquired HIV
Infectious Disease
S38 - All Things HIV and ID (3:54 PM-4:06 PM)
003

Neurodevelopmental impairment is common in children with pHIV, but little is known about the cognitive profile of adults living with pHIV. Additionally, there is no singular imaging correlate of cognitive impairment in persons living with HIV (PLWH). Myelin water imaging (MWI) quantifies global and regional myelin content utilizing differences in relaxation times of water trapped within the myelin bilayer compared to free water. We determined the cognitive profile and examined the correlation between MWF, a metric of myelin content acquired on MWI, and cognition in virally suppressed adults living with pHIV.

To describe cognitive outcomes in virally suppressed adults living with perinatally acquired HIV (pHIV) and to demonstrate the association between myelin water fraction (MWF), a novel imaging biomarker of myelin content, and cognition in our cohort

Seventeen adults over 21 years of age with pHIV, virally suppressed on ART, underwent an 11-test cognitive battery covering seven domains. Raw scores were adjusted for age, education, sex, and race/ethnicity and domain specific z-scores were determined using normative data. GRASE acquisition sequence was used for MWI data processing to determine global and frontal lobe MWF values. Correlations were assessed using Spearman rank correlation coefficient.

Ten (58%) virally suppressed adults living with pHIV were cognitively impaired with the lowest scores in the gross motor (average z-score: -2.9) and verbal memory (average z-score: -1.5) domain. Executive function scores were significantly higher in those with higher global MWF (Spearman r: 0.762, p: 0.037).  

Cognitive impairment is common among our cohort of adults living with virally suppressed pHIV, particularly in the gross motor domain. This may be due to a legacy effect on motor development as individuals in this cohort were born during a period when access to ART was limited. Reduced MWF, a marker of demyelination, may be an imaging biomarker for HIV-related cognitive impairment.  

Authors/Disclosures
Payal B. Patel, MD
PRESENTER
The institution of Dr. Patel has received research support from National Institute of Health. The institution of Dr. Patel has received research support from AHRQ. Dr. Patel has received personal compensation in the range of $0-$499 for serving as a Author with MedLink Neurology.
No disclosure on file
No disclosure on file
Jennifer Chiarella (Yale School of Medicine) No disclosure on file
Shannon Kolind, PhD, MSc, BSc (University of British Columbia) Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
No disclosure on file
Serena Spudich, MD (Yale University) The institution of Dr. Spudich has received research support from NIH.
Christina Marra, MD, FAAN (University of Washington, Harborview Medical Center) Dr. Marra has received publishing royalties from a publication relating to health care. Dr. Marra has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
No disclosure on file
No disclosure on file